Controlled Clinical Trials

Publisher: Elsevier

Founded in: 1976

Total resources: 2

E-ISSN: 1879-050X

ISSN: 0197-2456

Subject: R4 Clinical Medicine

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Controlled Clinical Trials

Menu

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics

By Bots M.L., Evans G.W., Riley W., Meijer R., McBride K.H., Paskett E.D., Helmond F.A., Grobbee D.E., for the OPAL Investigators in (2003)

Controlled Clinical Trials , Vol. 24, Iss. 6, 2003-12 , pp. 752-775

Elsevier

Abstract Access to resources Recommend Favorite

Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods

By Beanlands R., Nichol G., Ruddy T.D., deKemp R.A., Hendry P., Humen D., Racine N., Ross H., Benard F., Coates G., Iwanochko R.M., Fallen E., Wells G., The PARR-2 Investigators in (2003)

Controlled Clinical Trials , Vol. 24, Iss. 6, 2003-12 , pp. 776-794

Elsevier

Abstract Access to resources Recommend Favorite

Limiting loss to follow-up in a multicenter randomized trial in orthopedic surgery

By Sprague S., Leece P., Bhandari M., Tornetta P., Schemitsch E., Swiontkowski M.F., on behalf of the S.P.R.I.N.T. Investigators in (2003)

Controlled Clinical Trials , Vol. 24, Iss. 6, 2003-12 , pp. 719-725

Elsevier

Abstract Access to resources Recommend Favorite

Preface

By Neaton J.D. in (2003)

Controlled Clinical Trials , Vol. 24, Iss. 6, 2003-12 , pp. 667-668

Elsevier

Abstract Access to resources Recommend Favorite